Cargando…
Novel Therapeutic Targets in Cutaneous Squamous Cell Carcinoma
Cutaneous squamous cell carcinoma (SCC) is one of the common cancers in Caucasians, accounting for 20–30% of cutaneous malignancies. The risk of metastasis is low in most patients; however, aggressive SCC is associated with very high mortality and morbidity. Although cutaneous SCC can be treated wit...
Autores principales: | Yanagi, Teruki, Kitamura, Shinya, Hata, Hiroo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876309/ https://www.ncbi.nlm.nih.gov/pubmed/29629337 http://dx.doi.org/10.3389/fonc.2018.00079 |
Ejemplares similares
-
Eribulin inhibits growth of cutaneous squamous cell carcinoma cell lines and a novel patient-derived xenograft
por: Hsu, Che-Yuan, et al.
Publicado: (2023) -
TRIM29 in Cutaneous Squamous Cell Carcinoma
por: Hsu, Che-Yuan, et al.
Publicado: (2021) -
Immunotherapy for the Treatment of Cutaneous Squamous Cell Carcinoma
por: Boutros, Andrea, et al.
Publicado: (2021) -
The Roles of lncRNA in Cutaneous Squamous Cell Carcinoma
por: Wang, Yujia, et al.
Publicado: (2020) -
Immunotherapy for Cutaneous Squamous Cell Carcinoma: Results and Perspectives
por: Alberti, Andrea, et al.
Publicado: (2022)